All stock reports

BELLACASA evidence report

Evidence date: 2026-10-01. Research observations only.

What can I do with this stock?

Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.

Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.

Today: intraday

Evidence unavailable

No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

  • No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

Next week: five trading sessions

No qualifying opportunity

No candidate with a primary five-session horizon in the coherent source run.

  • No candidate with a primary five-session horizon in the coherent source run.

Long term: one to three years

Research only

A financial screen alone does not establish an investment recommendation.

  • A current, source-backed thesis and valuation review is required.

Investment evidence

Statement coverage
FULL_STATEMENTS
Financial source retrieved
2026-08-31T23:40:11.840150+00:00

Metrics

latest_annual_period
2026-03-31
revenue
4163966999.0
net_income
201272000.0
operating_cash_flow
391378000.0
free_cash_flow
-72303000.0
total_assets
3015015000.0
total_liabilities
1344143000.0
total_equity
1670872000.0
cash
321189000.0
total_debt
786213000.0
revenue_growth
0.1947552580120826
earnings_growth
107.99805855737546
net_margin
0.04833659826034563
roe
0.12045925720222735
debt_to_equity
0.4705405321293313
cash_conversion
1.9445228347708574
free_cash_flow_margin
-0.017363970467912923
trailing_pe
16.0502
forward_pe
0.0
peg_ratio
Not supplied
price_to_book
1.9378
dividend_yield
0.0

Other positional research

Research only

1 opportunity assessments; compare evidence and conditions below.

Price Dislocation

Research only. Direction: LONG.

Flags large price dislocations for research without asserting unsupported fundamental quality

  • No active, unexpired validation authority for this exact strategy and horizon.
  • A source-backed entry, invalidation, exit and cost plan is not supplied.
Eligible expression
None selected
Expression comparison
No eligible instrument selected.
Invalidation
Continued price deterioration or adverse fundamental evidence
Entry rule
Not supplied
Entry range (INR)
Not supplied
Exit / review rule
Not supplied
Planned exit
Not supplied
Plan valid until
Not supplied
Promotion reference
Not supplied
Instrument scenarios in INR; quantities are illustrative, not personal sizing
InstrumentEvidence statusContractQuantityCapital / marginTarget P&L after costsStop-level scenario P&LStress lossConditions and limitations
NO_POSITIONAvailableNot suppliedNot suppliedNot supplied0.000.00Not suppliedNo new position; incremental trading P&L is zero.
CASHUnavailableNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedObserved contract, quote and cost evidence not supplied.
FUTURESUnavailableNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedObserved contract, quote and cost evidence not supplied.
OPTIONSUnavailableNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedObserved contract, quote and cost evidence not supplied.
  • No reader capital or loss budget supplied
Decision provenance and limitations
Decision ID
decision-3117042819565ff358036d2043ed59bde77b9692c10969ba7dbe7947c6aade3f
Policy
stock-decisions-v1
Evidence bundle hash
e24f1bcd93c4071bc3ca712eb0dc3c8350806f6ed0c55db2ee34e082f2c6fb67
  • market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
  • validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
  • financial-statements: 0b8b5f86634fe6b3517615f29e8fd000d649273bd1d9033d4709cfb3bde21045
  • daily-price: 335ad1935c76246e22bceb0dd5251c947e83fd22222143ad60c7d9c38876377f
  • Conditional research decisions are not orders or personalized position sizes.
  • Scenario payoffs are assumptions, not probabilities or expected returns.
  • A stop price does not guarantee a maximum loss through a gap or illiquidity.

Download the decision evidence as JSON

Evidence briefing

The local language model selected and grouped the following supplied facts.

Overview

Price source verification: REPAIRED. The trailing 5-session price return was -11.43%. The trailing 20-session price return was -0.69%. The trailing 60-session price return was -5.18%. The trailing 250-session price return was -39.70%. Average cached traded value over twenty sessions was INR 4,325,471.

Risks

The closing price was -48.86% below its highest close in the available trailing year. The cached financial metric free cash flow margin is -0.017363970467912923. Historical observations do not establish future returns. No verified current news or catalyst evidence is supplied.

Follow Up

The cached financial metric latest annual period is 2026-03-31. The cached financial metric revenue growth is 0.1947552580120826. The cached financial metric net margin is 0.04833659826034563. The cached financial metric roe is 0.12045925720222735. The cached financial metric debt to equity is 0.4705405321293313. The cached financial metric cash conversion is 1.9445228347708574.

Cached observations and evidence limits